{
    "clinical_study": {
        "@rank": "163176", 
        "arm_group": [
            {
                "arm_group_label": "Clopidogrel", 
                "arm_group_type": "Experimental", 
                "description": "Continue home dose of clopidogrel into surgery"
            }, 
            {
                "arm_group_label": "Discontinue", 
                "arm_group_type": "Active Comparator", 
                "description": "Discontinue  home dose of clopidogrel one week before surgery.  Resume after surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "Patients who on taking clopidogrel are randomized to either continue clopidogrel into\n      general surgery or discontinue clopidogrel 7 days before surgery.  All patients resume\n      clopidogrel after surgery.  The investigators track the development of bleeding\n      complications that may develop within 90 days of the surgery.  Patients are medically\n      cleared to be in either arm of the study by their cardiologist and surgeon.  There is\n      currently no evidence to support for or against the use continuation or discontinuation of\n      clopidogrel prior to general surgery."
        }, 
        "brief_title": "Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Clopidogrel", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  taking clopidogrel\n\n          -  undergoing general surgery\n\n          -  cleared by both cardiologist and surgery for randomized arm\n\n        Exclusion Criteria:\n\n          -  previous history of bleeding complications/bleeding disposition\n\n          -  no capacity to consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960296", 
            "org_study_id": "GCO 10-1067"
        }, 
        "intervention": [
            {
                "arm_group_label": "Clopidogrel", 
                "description": "Continue home dose of clopidogrel into surgery", 
                "intervention_name": "Clopidogrel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Discontinue", 
                "description": "Discontinue  home dose of clopidogrel one week before surgery.  Resume after surgery.", 
                "intervention_name": "Discontinue Clopidogrel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clopidogrel", 
                "Ticlopidine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "clopidogrel", 
            "general surgery"
        ], 
        "lastchanged_date": "April 11, 2014", 
        "location": {
            "contact": {
                "email": "edward.chu@mountsinai.org", 
                "last_name": "Edward Chu, MD", 
                "phone": "407-616-7890"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10029"
                }, 
                "name": "Icahn School of Medicine at Mount Sinai"
            }, 
            "investigator": {
                "last_name": "Celia M Divino, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Clopidogrel Use in Peri-Operative General Surgery Patients: A Prospective Study", 
        "overall_contact": {
            "email": "malika.garg@mountsinai.org", 
            "last_name": "Malika Garg, MD", 
            "phone": "212-241-1982"
        }, 
        "overall_contact_backup": {
            "email": "celia.divino@mountsinai.org", 
            "last_name": "Celia M Divino, MD", 
            "phone": "212-241-3348"
        }, 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Celia M Divino, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Development of perioperative bleeding complications, including need for blood transfusions, hematoma, and bleeding requiring re-admission or re-operation", 
            "measure": "Perioperative Bleeding Complications", 
            "safety_issue": "Yes", 
            "time_frame": "up to 90 days post op"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960296"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Development of myocardial infarction or thrombosis", 
            "safety_issue": "No", 
            "time_frame": "up to 90 days"
        }, 
        "source": "Mount Sinai School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "Doris Duke Charitable Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}